Pharmabiz4h
CPHI & PMEC India 2024 kickstarts with expo, key discussions
Curtains were raised for the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, India’s leading B2B events organiser, with discussions on pivotal themes and closed door meetings ...
Pharmabiz19m
Bio-Techne Corporation partners with Leader Life Sciences to distribute Bio-Techne's portfolio across GCC countries
Bio-Techne Corporation, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, has announced a partnership with Leader ...
Pharmabiz2h
Sartorius Stedim Biotech opens new center for bioprocess innovation in Marlborough
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed ...
Pharmabiz1h
DURECT Corporation announces sale of Alzet product line to Lafayette Instrument for $17.5 million
DURECT Corporation, a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions such as acute organ ...
Pharmabiz14h
US FDA accepts for review GSK’s Blenrep combinations for the treatment of relapsed/refractory multiple myeloma
US FDA accepts for review GSK’s Blenrep combinations for the treatment of relapsed/refractory multiple myeloma: London, UK Tuesday, November 26, 2024, 09:00 Hrs [IST] GSK plc an ...
Pharmabiz8h
Merck announces pivotal phase 3 ZENITH trial evaluating Winrevair meets primary endpoint at interim analysis
Merck announces pivotal phase 3 ZENITH trial evaluating Winrevair meets primary endpoint at interim analysis: Rahway, New Jersey Tuesday, November 26, 2024, 15:00 Hrs [IST] Merck, ...
Pharmabiz12h
US FDA approves Roche’s companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with Ziihera
US FDA approves Roche’s companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with Ziihera: Tucson, Arizona Tuesday, November ...
Pharmabiz11h
TN IPGA's 63rd NPW celebration wants UPSC to include pharmacy as an optional subject into the civil services exam
TN IPGA's 63rd NPW celebration wants UPSC to include pharmacy as an optional subject into the civil services exam: Our Bureau, Mumbai Tuesday, November 26, 2024, 12:50 Hrs [IST] T ...
Pharmabiz11h
SVKM's BNCP discusses industry academia collaboration at Industry Connect Conclave 2024 in Mumbai
SVKM's BNCP discusses industry academia collaboration at Industry Connect Conclave 2024 in Mumbai: Our Bureau, Mumbai Tuesday, November 26, 2024, 12:40 Hrs [IST] SVKM's Dr Bhanube ...
Pharmabiz15h
Indian bio-pharma needs to shore-up its IP wealth with advanced research & innovation: Dr Jitendra Kumar
Indian bio-pharma needs to shore-up its IP wealth with advanced research & innovation: Dr Jitendra Kumar: Nandita Vijayasimha, Bengaluru Tuesday, November 26, 2024, 08:00 Hrs [IST ...
Pharmabiz9h
Adragos Pharma acquires Swiss-based sterile fill-finish expert, iBaccinex
Adragos Pharma acquires Swiss-based sterile fill-finish expert, iBaccinex: Munich, Germany Tuesday, November 26, 2024, 14:00 Hrs [IST] Adragos Pharma, a global pharmaceutical cont ...
Pharmabiz12h
Superspeciality Lens Symposium 2024 brings global experts to Mumbai
Superspeciality Lens Symposium 2024 brings global experts to Mumbai: Our Bureau, Mumbai Tuesday, November 26, 2024, 11:30 Hrs [IST] The Superspeciality Lens Symposium 2024, which ...